MA, S., MA, G., AR, M., & HI, E. (2022). New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity. European journal of medicinal chemistry, 241, 114661. https://doi.org/10.1016/j.ejmech.2022.114661
Chicago Style (17th ed.) CitationMA, Sabry, Ghaly MA, Maarouf AR, and El-Subbagh HI. "New Thiazole-based Derivatives as EGFR/HER2 and DHFR Inhibitors: Synthesis, Molecular Modeling Simulations and Anticancer Activity." European Journal of Medicinal Chemistry 241 (2022): 114661. https://doi.org/10.1016/j.ejmech.2022.114661.
MLA (9th ed.) CitationMA, Sabry, et al. "New Thiazole-based Derivatives as EGFR/HER2 and DHFR Inhibitors: Synthesis, Molecular Modeling Simulations and Anticancer Activity." European Journal of Medicinal Chemistry, vol. 241, 2022, p. 114661, https://doi.org/10.1016/j.ejmech.2022.114661.